Loading…

Inhibition of Anchorage-Independent Growth of Tumor Cells by IT-62-B, a New Anthracycline

IT-62-B, a new anthracycline isolated from fermentation broths of Streptomyces sp. IT-62, reversed certain tumor cell phenotypes in vitro including some of human origin. The observed normal phenotypes were anchorage dependence of cell growth, flattened cell morphology and restoration of actin stress...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antibiotics 1997/10/25, Vol.50(10), pp.853-859
Main Authors: TSUCHIYA, KAYOKO S., ISHII, TOMONORI, IKENO, SOUICHI, KUNIMOTO, SETSUKO, KAWAUCHI, TAKASHI, OTANI, TOSHIO, HORI, MAKOTO
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IT-62-B, a new anthracycline isolated from fermentation broths of Streptomyces sp. IT-62, reversed certain tumor cell phenotypes in vitro including some of human origin. The observed normal phenotypes were anchorage dependence of cell growth, flattened cell morphology and restoration of actin stress fibers. The extent of the anchorage dependence of cell growth induced by IT-62-B was generally greater than that by doxorubicin or pirarubicin. The cell-flattening effect of IT-62-B on cells of T24 (human bladder), but not on C-33A (human cervix), accompanied inhibition of fos gene expression. T24 cells, once flattened by IT-62-B, retained their flat morphology even in drug-free, fresh medium and eventually died in several days. IT-62-B, unlike doxorubicin, only slightly inhibited the topoisomerase II reaction in vitro and DNA synthesis in isolated cell nuclei.
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.50.853